Literature DB >> 8139001

Mutation of either of two cysteine residues or deletion of the amino or carboxy terminus of nonstructural protein NS1 of bluetongue virus abrogates virus-specified tubule formation in insect cells.

K Monastyrskaya1, T Booth, L Nel, P Roy.   

Abstract

Virus-specific tubules are characteristic of orbivirus infections and are likely to play an important role in virus morphogenesis. It has been shown that for bluetongue virus (BTV), the prototype orbivirus in the family Reoviridae, the virus-encoded NS1 protein forms tubules in insect cells when the BTV segment M6 gene is expressed by using a baculovirus vector. To understand the function of NS1 tubules and to identify the sequences involved in their polymerization, a series of mutant NS1 genes was generated and expressed in insect cell cultures by using baculovirus vectors. Three of the mutants were deletion mutants. One (AcNS1.dNT10) lacked 10 of the amino-terminal amino acids, and the other two mutants (AcNS1.dCT20 and AcNS1.dCT43) lacked 20 or 43 of the carboxy-terminal amino acids. In addition, site-directed mutants were constructed in which various single cysteines or pairs of cysteines were changed to serines. The ability of each mutant protein to form tubules was investigated. None of the deletion mutants formed tubules. The constructs in which the cysteines at amino acid positions 337 and/or 340 were replaced by serines (e.g., AcNS1.C337S,C340S) also did not form tubules. Instead, the NS1 protein of these and the deletion mutants made ribbon-like structures which formed large aggregates. Mutations involving six other cysteines (i.e., AcNS1.C37S,C43S,AcNS1.C462S,C465S, AcNS1.C104S, and AcNS1.C364S) produced tubules. The results show that both the amino and carboxy termini of the NS1 protein molecule and the cysteines at residues 337 and 340 are essential for tubule formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139001      PMCID: PMC236692     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Protein synthesis in bluetongue virus-infected cells.

Authors:  H Huismans
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  Characterization of the tubules associated with the replication of three different orbiviruses.

Authors:  H Huismans; H J Els
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

3.  Complete sequence of the NS1 gene (M6 RNA) of US bluetongue virus serotype 10.

Authors:  J Lee; P Roy
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

4.  Tubules with viruslike particles in leaf cells infected with bean pod mottle virus.

Authors:  K S Kim; J P Fulton
Journal:  Virology       Date:  1971-02       Impact factor: 3.616

Review 5.  Microtubule-associated proteins.

Authors:  J B Olmsted
Journal:  Annu Rev Cell Biol       Date:  1986

6.  High-sequence conservation among the United States bluetongue viruses cognate M2 genes which encode the nonstructural NS1 tubule protein.

Authors:  G Y Hwang; J F Chiou; Y Y Yang; J K Li
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

Review 7.  Biochemistry and physiology of microtubules.

Authors:  J A Snyder; J R McIntosh
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

8.  Biochemistry of the filaments of brain.

Authors:  S H Yen; D Dahl; M Schachner; M L Shelanski
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  A morphological study of the replication of Breda virus (proposed family Toroviridae) in bovine intestinal cells.

Authors:  J A Fagerland; J F Pohlenz; G N Woode
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

View more
  7 in total

1.  Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.

Authors:  Natasha Larke; Aileen Murphy; Christoph Wirblich; Denise Teoh; Marie J Estcourt; Andrew J McMichael; Polly Roy; Tomás Hanke
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Drosophila melanogaster as a model organism for bluetongue virus replication and tropism.

Authors:  Andrew E Shaw; Eva Veronesi; Guillemette Maurin; Najate Ftaich; Francois Guiguen; Frazer Rixon; Maxime Ratinier; Peter Mertens; Simon Carpenter; Massimo Palmarini; Christophe Terzian; Frederick Arnaud
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

3.  Characterization and modification of the carboxy-terminal sequences of bluetongue virus type 10 NS1 protein in relation to tubule formation and location of an antigenic epitope in the vicinity of the carboxy terminus of the protein.

Authors:  K Monastyrskaya; E A Gould; P Roy
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.

Authors:  Randall J Owens; Chang Limn; Polly Roy
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Atomic structure of the translation regulatory protein NS1 of bluetongue virus.

Authors:  Adeline Kerviel; Peng Ge; Mason Lai; Jonathan Jih; Mark Boyce; Xing Zhang; Z Hong Zhou; Polly Roy
Journal:  Nat Microbiol       Date:  2019-02-18       Impact factor: 17.745

6.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

7.  Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment.

Authors:  Andrew E Shaw; Maxime Ratinier; Sandro Filipe Nunes; Kyriaki Nomikou; Marco Caporale; Matthew Golder; Kathryn Allan; Claude Hamers; Pascal Hudelet; Stéphan Zientara; Emmanuel Breard; Peter Mertens; Massimo Palmarini
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.